Bulletin
Investor Alert

Bayer AG ADR

OTC: BAYRY

GO
/marketstate/country/us

Market closed

/zigman2/quotes/203424967/delayed

$

16.33

Change

+0.22 +1.37%

Volume

Volume 332,468

Jan 20, 2021, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203424967/delayed

Previous close

$ 16.11

$ 16.33

Change

+0.22 +1.37%

Day low

Day high

$16.18

$16.33

Open
Open: 16.27

52 week low

52 week high

$11.75

$21.49

Open

Market cap

$63.16B

Average volume

618,790

P/E ratio

N/A

Rev. per Employee

$469,426

EPS

-2.68

Dividend

0.76

Div yield

3.25%

Ex dividend date

4/29/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bayry

MarketWatch News on BAYRY

  1. Bayer's new prostate cancer drug beats sales view

    5:40 a.m. Jan. 13, 2021

    - MarketWatch.com

  2. Bayer to partner with CureVac on COVID-19 vaccine

    2:53 a.m. Jan. 7, 2021

    - MarketWatch.com

  3. Bayer launches cell and gene therapy platform

    6:09 a.m. Dec. 2, 2020

    - MarketWatch.com

  4. Stocks Close Higher on Stimulus Hopes, Manufacturing Data

    6:03 p.m. Dec. 1, 2020

    - Barron's Online

  5. Bayer to raise $1.65B through Elanco share sale

    2:18 a.m. Dec. 1, 2020

    - MarketWatch.com

  6. Elanco Animal Health Stock Stumbles After Earnings Report

    1:42 p.m. Nov. 6, 2020

    - Barron's Online

  7. Bayer backs 2020 outlook, but posts loss

    2:04 a.m. Nov. 3, 2020

    - MarketWatch.com

  8. George Floyd’s Death Leads to a Surge of New Black Board Members

    8:31 p.m. Oct. 30, 2020

    - Barron's Online

  9. Bayer Is Betting on Gene Therapy With a $4 Billion U.S. Acquisition

    10:37 a.m. Oct. 26, 2020

    - Barron's Online

  10. Bayer to pay up to $4 billion for Asklepios Bio

    2:43 a.m. Oct. 26, 2020

    - MarketWatch.com

  11. Bayer late lymphoma study meets primary endpoint

    2:07 a.m. Oct. 14, 2020

    - MarketWatch.com

  12. Stocks Close Up Slightly as Stimulus Talks Falter

    3:13 p.m. Oct. 1, 2020

    - Barron's Online

  13. Bayer unveils billions in new cost cuts

    7:21 p.m. Sept. 30, 2020

    - MarketWatch.com

  14. Bayer extends CEO's contract

    12:37 a.m. Sept. 11, 2020

    - MarketWatch.com

  15. Dow Turns Positive for the Year as the Dollar Falls

    3:41 p.m. Aug. 28, 2020

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bayry

Other News on BAYRY

  1. Merck/Bayer's Verquvo OK'd in U.S. for chronic heart failure

    7:14 a.m. Jan. 20, 2021

    - Seeking Alpha

  2. Bayer to examine the production of CureVac’s COVID-19 jab

    11:13 p.m. Jan. 16, 2021

    - Seeking Alpha

  3. Siemens: A Fairly Priced Industry Leader

    10:51 p.m. Jan. 10, 2021

    - Seeking Alpha

  4. CureVac, Bayer agree to COVID-19 vaccine alliance - report

    7:38 p.m. Jan. 6, 2021

    - Seeking Alpha

  5. Bayer At Its Cheapest In A Decade

    5:05 p.m. Jan. 6, 2021

    - Seeking Alpha

  6. Agriculture Industry Bets on Carbon as a New Cash Crop

    5:30 a.m. Dec. 23, 2020

    - Jacob Bunge

  7. Calyxt To Exit Farming Operations And Focus On Seed Science

    10:45 a.m. Dec. 10, 2020

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/bayry

Press Releases on BAYRY

  1. Global cancer immunotherapy market valuation to cross USD 1 billion by 2026

    2:12 p.m. Jan. 20, 2021

    - Market Insight Reports

  2. Organic Farming Market Views: Taking A Nimble Approach To 2021

    7:15 a.m. Jan. 20, 2021

    - Market Insight Reports

  3. Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

    6:45 a.m. Jan. 20, 2021

    - BusinessWire - BZX

  4. Animal Parasiticides Market Size to Register 7.2% CAGR Through 2027

    6:42 a.m. Jan. 20, 2021

    - Market Insight Reports

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.